NFE2L2 and age-related macular degeneration: Although cell experiments alone may not be sufficient to demonstrate the clinical usefulness of Nrf2 for treating DR and AMD, they do suggest that further research is warranted to determine whether it may have therapeutic potential for these conditions [143].